Uncovering the cause of pneumonia: reactivation of HHV-6B in an immunocompromised patient
Human herpesvirus 6 (HHV-6) can reactivate in immunocompromised individuals and cause severe atypical pneumonia, so it is important to recognise this entity when a patient fails to improve their clinical outcome with conventional therapy.In patients diagnosed with pneumonitis, DNA PCR testing can detect HHV-6 from bronchoalveolar lavage fluid making this a powerful diagnostic tool.Treatment options for HHV-6 pneumonitis should be considered, such as combined ganciclovir and foscarnet or, as in our case, oral valganciclovir can be a good alternative.
Authors
- João Fonseca (ORCID: https://orcid.org/0000-0003-1624-7801)
- Filipa Ferreira (ORCID: https://orcid.org/0000-0001-9474-0111)
- Daniela Alves (ORCID: https://orcid.org/0000-0001-6709-0504)
- Juliana Nogueira (ORCID: https://orcid.org/0000-0003-4858-8774)
- Leonor Rodrigues (ORCID: https://orcid.org/0000-0002-1067-6544)
Institutions
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- University of Aveiro (PT)
Publication Details
- Journal
- European Journal of Case Reports in Internal Medicine
- Published
- 2025-09-16
- DOI
- https://doi.org/10.12890/2025_005783
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00